4
Changes in Ownership
Serina Therapeutics, Inc. Filed Acc 0001301120-25-000005
Chief Scientific Officer sold 47,674 shares at an average $6.95 ($331,418)
- Chief Scientific Officer acquired 47,674 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Moreadith Randall · Chief Scientific Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-25 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,042 | $0.06 | $123 | 2,042 | D |
| 2025-08-26 | Exercise or conversion : show line 2 in the form 10b5-1 | +45,632 | $0.06 | $2,738 | 45,632 | D |
| 2025-08-25 | Sale : show line 3 in the form 10b5-1 | −2,042 | $5.65 | $11,537 | 0 | D |
| 2025-08-26 | Sale : show line 4 in the form 10b5-1 | −45,632 | $7.01 | $319,880 | 0 | D |
| Open-market sales · 47,674 sh · avg $6.95 · $331,418 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-08-25 | Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) | −2,042 | 467,144 | D |
| 2025-08-26 | Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (right to buy) | −45,632 | 421,512 | D |
Loading xslF345X05/wk-form4_1756329396.xml…